BERNARDI, ANNA
BERNARDI, ANNA
Dipartimento di Chimica
Toward Dual-Target Glycomimetics against Two Bacterial Lectins to Fight Pseudomonas aeruginosa−Burkholderia cenocepacia Infections: A Biophysical Study
2025 G. Antonini, M. Fares, D. Hauck, P. Mała, E. Gillon, L. Belvisi, A. Bernardi, A. Titz, A. Varrot, S. Mazzotta
Synthesis of α‐Arylglycosides by Ni‐Photoredox Arylation of Sugars with an Organic Photocatalyst
2025 G. Cavazzoli, I. Gamberoni, S. Mazzotta, A. Bossi, M. Penconi, A. Bernardi, L. Pignataro
Polyvalent Glycomimetic-Gold Nanoparticles Revealing Critical Roles of Glycan Display on Multivalent Lectin–Glycan Interaction Biophysics and Antiviral Properties
2024 X. Ning, D. Budhadev, S. Pollastri, I. Nehlmeier, A. Kempf, I. Manfield, W.B. Turnbull, S. Pöhlmann, A. Bernardi, X. Li, Y. Guo, D. Zhou
Unprecedented selectivity for homologous lectin targets: differential targeting of the viral receptors L-SIGN and DC-SIGN
2024 C. Delaunay, S. Pollastri, M. Thépaut, G. Cavazzoli, L. Belvisi, C. Bouchikri, N. Labiod, F. Lasala, A. Gimeno, A. Franconetti, J. Jiménez-Barbero, A. Ardá, R. Delgado, A. Bernardi, F. Fieschi
Improving ligand affinity through covalent strategies: the case of BC2L-C bacterial lectin
2024 G. Antonini, S. Mazzotta, I. Giussani, A. Varrot, A. Bernardi, L. Belvisi
Design, synthesis and biophysical evaluation of covalent ligands targeting a lysine residue in BC2L-C bacterial lectin
2024 G. Antonini, A. Varrot, A. Bernardi, L. Belvisi, S. Mazzotta
Polyvalent Glycomimetic-Gold Nanoparticle Conjugates reveal effects of glycan display on Multivalent Lectin-Glycan Interactions
2024 X. Ning, D. Budhadev, S. Pollastri, I. Nehlmeier, A. Kempf, I. Manfield, B. Turnbull, S. Pöhlmann, A. Bernardi, X. Li, Y. Guo, D. Zhou
Achieving high affinity for a bacterial lectin with reversible covalent ligands
2024 G. Antonini, A. Bernardi, E. Gillon, A. Dal Corso, M. Civera, L. Belvisi, A. Varrot, S. Mazzotta
A Practical, Scalable Synthesis of 1,18‐Octadecanedioic acid‐Paclitaxel (ODDA‐PTX)
2024 V. Rositano, A. Gambini, P. Allegrini, A. Bernardi, L. Senaldi
Novel Glycomimetics as First Antagonists of Burkholderia Cenocepacia Lectin BC2L-C-Nt: Design and Synthesis of β-C- and β-N-fucosides
2023 S. Mazzotta, R. Bermeo, G. Antonini, K. Lal, R. Guerini, F. Vasile, A. Imberty, L. Belvisi, A. Varrot, A. Bernardi
Developing glycomimetic inhibitors for the N-terminal domain of the bacterial lectin BC2L-C through covalent strategies
2023 G. Antonini, S. Mazzotta, A. Varrot, A. Bernardi, L. Belvisi
Towards covalent ligands for the N-terminal domain of the bacterial lectin BC2L-C
2023 G. Antonini, S. Mazzotta, R. Guerini, A. Varrot, A. Bernardi, L. Belvisi
Development of a highly selective glycomimetic ligand for L-SIGN: a new tool against SARS-CoV-2 and Ebola viruses
2023 C. Delaunay, S. Pollastri, M. Thépaut, G. Cavazzoli, L. Belvisi, C. Bouchikri, N. Labiod, A. Gimeno, A. Franconetti, J. Jiménez-Barbero, A. Ardá, R. Delgado, A. Bernardi, F. Fieschi
Identification of New L-Fucosyl and L-Galactosyl Amides as Glycomimetic Ligands of TNF Lectin Domain of BC2L-C from Burkholderia cenocepacia
2023 S. Mazzotta, G. Antonini, F. Vasile, E. Gillon, J. Lundstrøm, A. Varrot, L. Belvisi, A. Bernardi
Novel β-C and β-N fucosides as first synthetic ligands for BC2L-C N-term lectin from B. cenocepacia
2023 S. Mazzotta, R. Bermeo, K. Lal, G. Antonini, F. Vasile, A. Imberty, L. Belvisi, A. Varrot, A. Bernardi
Scalemic natural products
2023 S. Mazzotta, V. Rositano, L. Senaldi, A. Bernardi, P. Allegrini, G. Appendino
Powerful Avidity with a Limited Valency for Virus-Attachment Blockers on DC-SIGN: Combining Chelation and Statistical Rebinding with Structural Plasticity of the Receptor
2023 V. Porkolab, M. Lepšík, S. Ordanini, A. St John, A. Le Roy, M. Thépaut, E. Paci, C. Ebel, A. Bernardi, F. Fieschi
Glycomimetic antagonists of BC2L-C lectin: insights from Molecular Dynamics simulations
2023 G. Antonini, M. Civera, K. Lal, S. Mazzotta, A. Varrot, A. Bernardi, L. Belvisi
Novel Glycomimetic Ligands for Bacterial Lectins: Design, Synthesis and Biophysical Evaluation
2022 S. Mazzotta, R. Bermeo, K. Lal, G. Antonini, F. Vasile, A. Imberty, L. Belvisi, A. Varrot, A. Bernardi
C2-Triazole-modified mannose-based L-SIGN antagonists
2022 S. Pollastri, C. Delaunay, M. Thépaut, F. Fieschi, A. Bernardi